A New Addition to the Carl Icahn Portfolio
This week, Carl Icahn, the notorious corporate raider and billionaire investor, set his eyes on a new target: Bristol-Myers Squibb Co (NYSE:BMY). We dug through his regulatory filings to see if this position matches earlier Carl Icahn predictions, and what we found is big news for the Bristol Myers stock price.
Before now, investors were pricing BMY stock based on the firm’s cancer research. The company has poured tons of money into cancer research, hoping to find new treatments..
(Visited 1 times, 1 visits today). Overall Top Posts for today In Archives and Sidebar.